TRAVATAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug TRAVATAN contains one active pharmaceutical ingredient (API):

1	Travoprost UNII WJ68R08KX9 - TRAVOPROST
	Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways.
	Read more about Travoprost

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRAVATAN Eye drops, solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EE04	Travoprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5554H, 8597L
BR	Câmara de Regulação do Mercado de Medicamentos	500903801177316, 500912110006403
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01466172, 01466189, 16820509
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	363231112
EE	Ravimiamet	1097041, 1130454
ES	Centro de información online de medicamentos de la AEMPS	01199001, 01199001IP
FI	Lääkealan turvallisuus- ja kehittämiskeskus	517180, 581969
FR	Base de données publique des médicaments	60670806
GB	Medicines & Healthcare Products Regulatory Agency	140104, 182026, 26702, 375935, 377075
HK	Department of Health Drug Office	52367
IE	Health Products Regulatory Authority	54231, 78605, 78621, 78634, 78642
IL	מִשְׂרַד הַבְּרִיאוּת	4598
IT	Agenzia del Farmaco	035409010
LT	Valstybinė vaistų kontrolės tarnyba	1003997, 1009818, 1076196, 1080801
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	163M2001
NL	Z-Index G-Standaard	14771934
NL	Z-Index G-Standaard, PRK	61093
NZ	Medicines and Medical Devices Safety Authority	19306
PL	Rejestru Produktów Leczniczych	100108480
SG	Health Sciences Authority	11817P
TN	Direction de la Pharmacie et du Médicament	1903051, 20833031
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504612127
US	FDA, National Drug Code	0065-0260, 0078-0946
ZA	Health Products Regulatory Authority	36/15.4/0333